Caffeine-induced protein kinase A activation restores cognitive deficits induced by sleep deprivation by regulating O -GlcNAc cycling in adult zebrafish

• Published in: American Journal of Physiology: Cell Physiology Vol. 326; no. 3; p. C978
• Main Authors: Tran, Thuy-Duong Thi, Park, Jiwon, Kim, Dong Yeol, Han, Inn-Oc
• Format: Journal Article
• Language: English
• Published: United States 01-03-2024
• Subjects: Acetylglucosamine - metabolism; Animals; Caffeine - pharmacology; Cognition; Cognitive Dysfunction - drug therapy; Cyclic AMP-Dependent Protein Kinases - metabolism; Isoquinolines; N-Acetylglucosaminyltransferases - genetics; N-Acetylglucosaminyltransferases - metabolism; Protein Processing, Post-Translational; Rolipram; Sleep Deprivation - drug therapy; Sulfonamides; Zebrafish - metabolism; hexosamine; rolipram; caffeine; O-GlcNAc transferase; cognition
• ISSN: 1522-1563
• DOI: 10.1152/ajpcell.00691.2023

Sleep deprivation (SD) is widely acknowledged as a significant risk factor for cognitive impairment. In this study, intraperitoneal caffeine administration significantly ameliorated the learning and memory (L/M) deficits induced by SD and reduced aggressive behaviors in adult zebrafish. SD led to a reduction in protein kinase A (PKA) phosphorylation, phosphorylated-cAMP response element-binding protein (p-CREB), and c-Fos expression in zebrafish brain. Notably, these alterations were effectively reversed by caffeine. In addition, caffeine mitigated neuroinflammation induced by SD, as evident from suppression of the SD-mediated increase in glial fibrillary acidic protein (GFAP) and nuclear factor-κB (NF-κB) activation. Caffeine restored normal
-GlcNAcylation and
-GlcNAc transferase (OGT) levels while reversing the increased expression of
-GlcNAcase (OGA) in zebrafish brain after SD. Intriguingly, rolipram, a selective phosphodiesterase 4 (PDE4) inhibitor, effectively mitigated cognitive deficits, restored p-CREB and c-Fos levels, and attenuated the increase in GFAP in brain induced by SD. In addition, rolipram reversed the decrease in
-GlcNAcylation and OGT expression as well as elevation of OGA expression following SD. Treatment with H89, a PKA inhibitor, significantly impaired the L/M functions of zebrafish compared with the control group, inducing a decrease in
-GlcNAcylation and OGT expression and, conversely, an increase in OGA expression. The H89-induced changes in
-GlcNAc cycling and L/M dysfunction were effectively reversed by glucosamine treatment. H89 suppressed, whereas caffeine and rolipram promoted
-GlcNAc cycling in Neuro2a cells. Our collective findings underscore the interplay between PKA signaling and
-GlcNAc cycling in the regulation of cognitive function in the brain, offering potential therapeutic targets for cognitive deficits associated with SD.
Our observation highlights the intricate interplay between cAMP/PKA signaling and
-GlcNAc cycling, unveiling a novel mechanism that potentially governs the regulation of learning and memory functions. The dynamic interplay between these two pathways provides a novel and nuanced perspective on the molecular foundation of learning and memory regulation. These insights open avenues for the development of targeted interventions to treat conditions that impact cognitive function, including SD.